173 related articles for article (PubMed ID: 26256206)
1. Nano-engineering chitosan particles to sustain the release of promethazine from orodispersables.
Elwerfalli AM; Al-Kinani A; Alany RG; ElShaer A
Carbohydr Polym; 2015 Oct; 131():447-61. PubMed ID: 26256206
[TBL] [Abstract][Full Text] [Related]
2. Study of 5-Fluorouracil Loaded Chitosan Nanoparticles for Treatment of Skin Cancer.
Patel G; Yadav BKN
Recent Pat Nanotechnol; 2020; 14(3):210-224. PubMed ID: 31267881
[TBL] [Abstract][Full Text] [Related]
3. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
[TBL] [Abstract][Full Text] [Related]
4. Preparation of polyelectrolyte complex nanoparticles of chitosan and poly(2-acry1amido-2-methylpropanesulfonic acid) for doxorubicin release.
Zhang L; Wang J; Ni C; Zhang Y; Shi G
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():724-9. PubMed ID: 26478364
[TBL] [Abstract][Full Text] [Related]
5. Fast and pH-dependent release of domperidone from orally disintegrating tablets.
Assaf SM; Qandil AM; Al-Ani EA
Pharm Dev Technol; 2013; 18(4):897-905. PubMed ID: 22304659
[TBL] [Abstract][Full Text] [Related]
6. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
7. Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles.
Vandana M; Sahoo SK
Nanomedicine (Lond); 2009 Oct; 4(7):773-85. PubMed ID: 19839813
[TBL] [Abstract][Full Text] [Related]
8. Optimization of particle size and encapsulation efficiency of vancomycin nanoparticles by response surface methodology.
Honary S; Ebrahimi P; Hadianamrei R
Pharm Dev Technol; 2014 Dec; 19(8):987-98. PubMed ID: 24147898
[TBL] [Abstract][Full Text] [Related]
9. Chitosan grafted-poly(ethylene glycol) methacrylate nanoparticles as carrier for controlled release of bevacizumab.
Savin CL; Popa M; Delaite C; Costuleanu M; Costin D; Peptu CA
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():843-860. PubMed ID: 30813091
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-tripolyphosphate nanoparticles: Optimization of formulation parameters for improving process yield at a novel pH using artificial neural networks.
Hashad RA; Ishak RA; Fahmy S; Mansour S; Geneidi AS
Int J Biol Macromol; 2016 May; 86():50-8. PubMed ID: 26783636
[TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin loaded nanoparticles of disulfide bridged thiolated chitosan-eudragit RS100 for controlled drug delivery.
Iqbal O; Shah S; Abbas G; Rasul A; Hanif M; Ashfaq M; Afzal Z
Int J Biol Macromol; 2021 Jul; 182():2087-2096. PubMed ID: 34087298
[TBL] [Abstract][Full Text] [Related]
12. A sustained release formulation of chitosan modified PLCL:poloxamer blend nanoparticles loaded with optical agent for animal imaging.
Ranjan AP; Zeglam K; Mukerjee A; Thamake S; Vishwanatha JK
Nanotechnology; 2011 Jul; 22(29):295104. PubMed ID: 21693801
[TBL] [Abstract][Full Text] [Related]
13. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
Singh KH; Shinde UA
Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
[TBL] [Abstract][Full Text] [Related]
14. Development and Characterization of Chitosan Cross-Linked With Tripolyphosphate as a Sustained Release Agent in Tablets, Part I: Design of Experiments and Optimization.
Pinto CA; Saripella KK; Loka NC; Neau SH
J Pharm Sci; 2018 Apr; 107(4):1063-1075. PubMed ID: 29183743
[TBL] [Abstract][Full Text] [Related]
15. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
Pawar H; Douroumis D; Boateng JS
Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
[TBL] [Abstract][Full Text] [Related]
16. In vitro release and biological activities of Carum copticum essential oil (CEO) loaded chitosan nanoparticles.
Esmaeili A; Asgari A
Int J Biol Macromol; 2015 Nov; 81():283-90. PubMed ID: 26257380
[TBL] [Abstract][Full Text] [Related]
17. Two-step method for encapsulation of oregano essential oil in chitosan nanoparticles: preparation, characterization and in vitro release study.
Hosseini SF; Zandi M; Rezaei M; Farahmandghavi F
Carbohydr Polym; 2013 Jun; 95(1):50-6. PubMed ID: 23618238
[TBL] [Abstract][Full Text] [Related]
18. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Gan Q; Wang T; Cochrane C; McCarron P
Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures.
Chronopoulou L; Massimi M; Giardi MF; Cametti C; Devirgiliis LC; Dentini M; Palocci C
Colloids Surf B Biointerfaces; 2013 Mar; 103():310-7. PubMed ID: 23261553
[TBL] [Abstract][Full Text] [Related]
20. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
